| Shady Ahmed, PT, DPT | |
|
177 Fort Washington Ave, New York, NY 10032-3733 | |
| (212) 305-3280 | |
| Not Available |
| Full Name | Shady Ahmed |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 177 Fort Washington Ave, New York, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003208182 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Secondary |
| 225100000X | Physical Therapist | 40QA01589100 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shady Ahmed, PT, DPT 29 Rotunda Ln, South River, NJ 08882-2712 Ph: () - | Shady Ahmed, PT, DPT 177 Fort Washington Ave, New York, NY 10032-3733 Ph: (212) 305-3280 |
News Archive
A UCLA School of Nursing study has found that both healthy-weight and obese children who participated in an intensive lifestyle modification program significantly improved their metabolic and cardiovascular health despite little weight loss.
A protein-sugar molecule, CD99, occurs more frequently than normal on stem cells responsible for blood cancers, including acute myeloid leukemia (AML) and the related myelodysplastic syndromes.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the cost of Roche/Chugai's Avastin, followed by concerns about its efficacy and side-effect profile, are cited most frequently by surveyed oncologists as the factors preventing their use of Avastin for non-small-cell lung cancer treatment in Germany, France, Italy, Spain and the United Kingdom.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations and a primary focus in Hematology and Oncology, and Onxeo S.A., an innovative company specializing in the development of orphan oncology drugs, today jointly announced the results from their Phase 1 combination trial of belinostat (Beleodaq) with the CHOP (Cyclophosphamide, Hydroxyl-doxorubicin; Vincristine, and Prednisone) chemotherapy regimen as first-line treatment for newly diagnosed peripheral T-cell lymphoma (PTCL).
Emotional or behavioral problems may explain why some adolescents with psychotic symptoms find it hard to interact socially, researchers highlight.
› Verified 6 days ago
Wilbert Lao, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 37 W 26th St, Suite 302, New York, NY 10010 Phone: 718-285-0588 Fax: 718-285-9323 | |
Elisabeth Anne Frank, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 501 5th Ave, 22nd Floor, New York, NY 10017 Phone: 404-849-5770 | |
Ryanne Tanae Glasper, P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 230 W 38th St Fl 18, New York, NY 10018 Phone: 212-997-7490 Fax: 212-007-7492 | |
Miss Shari Ilise Nadel, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 147 W 35th St, Suite 407, New York, NY 10001 Phone: 917-591-8494 | |
Katherine Spencer, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 201 W 108th St Apt 41, New York, NY 10025 Phone: 585-737-2360 | |
Kunjan Shah, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 675 3rd Ave, 5th Floor, New York, NY 10017 Phone: 212-204-5144 | |
Mr. Ramoncito Tiosejo Dizon, RPT Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 1615 Madison Ave, New York, NY 10029 Phone: 212-860-5803 Fax: 212-860-6095 |